retatrutide addiction treatment Retatrutide—A Game Changer in Obesity Pharmacotherapy Extreme Side Effects Followed Overdose

Because it is controlled, prescribing it carries DEA compliance obligations that semaglutide does not

The weight loss effects observed with GLP-1 receptor agonists led to further investigation of these medications for obesity management in patients without diabetes

Who should and shouldnt use GLP-1 peptides a medically-backed breakdown of risk factors and contraindications

Drugs targeting GPCRs such as GLP-1RA, glucose-dependent insulinotropic polypeptide receptor (GIPR), and melanocortin-4 receptors (MC4R) have been approved for weight management and T2D (2, 3)

Some GLP-1 medications have evidence of cardiovascular risk reduction in specific patient groups

Our goal is to ensure you feel empowered and prepared for every mile of your trip